Clinical Trials List
2016-06-01 - 2023-05-31
Phase III
Terminated5
ICD-10C50
Malignant neoplasm of breast
ICD-9174.0
Malignant neoplasm of female breast, nipple and areola
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- YEN-SHEN LU Division of Hematology & Oncology
- Wei-Wu Chen Division of Hematology & Oncology
- 羅喬 Division of General Surgery
- 楊雅雯 Division of General Surgery
- 郭文宏 Division of General Surgery
- 張端瑩 Division of Hematology & Oncology
- MING-YANG WANG Division of General Surgery
- 蔡立威 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Audit
None
Taiwan National PI
Co-Principal Investigator
- Yi-Fang Tsai Division of General Surgery
- 金光亮 Division of General Surgery
- 林燕淑 Division of General Surgery
- Ta-Chung Chao Division of Hematology & Oncology
- 邱仁輝 Division of General Surgery
- Chun-Yu Liu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
4 Stop recruiting
Audit
None
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Chih-Jung Chen Division of General Surgery
- HWEI-CHUNG WANG Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Fang-Ming Chen Division of General Surgery
- Fu Ouyang Division of General Surgery
- Chieh-Han Chuang Division of General Surgery
- 甘蓉瑜 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
Audit
None
Co-Principal Investigator
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
272 participants
